Back
Silgan Holdings 10K Form
Buy
54
SLGN
Silgan Holdings
Last Price:
53.47
Seasonality Move:
5.3%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-08 | 10Q | SLGN/Silgan Holdings Quarterly |
2023-11-02 | 10Q | SLGN/Silgan Holdings Quarterly |
2023-08-03 | 10Q | SLGN/Silgan Holdings Quarterly |
2023-05-03 | 10Q | SLGN/Silgan Holdings Quarterly |
2022-11-03 | 10Q | SLGN/Silgan Holdings Quarterly |
2022-08-04 | 10Q | SLGN/Silgan Holdings Quarterly |
Receive SLGN News And Ratings
See the #1 stock for the next 7 days that we like better than SLGN
SLGN Financial Statistics
Sales & Book Value
Annual Sales: | $5.99B |
---|---|
Cash Flow: | $252.46M |
Price / Cash Flow: | 9.17 |
Annual Sales: | $19.24 |
Price / Book: | 2.76 |
Profitability
EPS (TTM): | 2.76000 |
---|---|
Net Income (TTM): | $295.79M |
Gross Margin: | $992.56M |
Return on Equity: | 15.47% |
Return on Assets: | 3.85% |
Silgan Holdings Earnings Forecast
Key Silgan Holdings Financial Ratios
- The Gross Profit Margin over the past 30 years for SLGN is 16.58%.
- The Selling, General & Administrative Expenses for SLGN have been equal to 6.49% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 53.17% of Operating Income.
- The Net Earning history of SLGN is 5.44% of Total Revenues.
- Per Share Earnings over the last 30 years have been positive in 16 years.
Silgan Holdings Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Containers & Packaging |
Sector: | Materials |
Current Symbol: | SLGN |
CUSIP: | 827048 |
Website: | silganholdings.com |
Debt
Debt-to-Equity Ratio: | 1.85 |
---|---|
Current Ratio: | 2.4 |
Quick Ratio: | 1.5 |
Price-to-Earnings
Trailing P/E Ratio: | 17.81 |
---|---|
Forward P/E Ratio: | 12.83 |
SLGN Technical Analysis vs Fundamental Analysis
Buy
54
Silgan Holdings (SLGN)
is a Buy
Is Silgan Holdings a Buy or a Sell?
-
Silgan Holdings stock is rated a Buy
The current Silgan Holdings [SLGN] share price is $53.07. The Score for SLGN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.